MYND Life Sciences's total assets for Q3 2024 were $719.72K, an increase of 1.66% from the previous quarter. MYNDF total liabilities were $6.71M for the fiscal quarter, a 6.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.